SCHEMBL6298094

SCHEMBL6298094

COc1ccc(N(Cc2ccc(CC(=O)O)cc2)C(=O)OCC2c3ccccc3-c3ccccc32)c(OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FABP5 Q01469 1/20 0.42
▸ NR3C1 P04150 2/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ AKR1C3 P42330 1/20 0.39
▸ AKR1C2 P52895 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ TP53 P04637 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ LPAR1 Q92633 1/20 0.37
▸ LPAR2 Q9HBW0 1/20 0.37
▸ TSHR P16473 3/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28069712 0.93 FABP5 (0.45) FABP5ALDH1A1MEN1KMT2ATSHR
SCHEMBL4784032 0.91 FABP5 (0.41) FABP5ALDH1A1MEN1KMT2ATSHR
SCHEMBL208874 0.91 FABP5 (0.41) FABP5ALDH1A1MEN1KMT2ATSHR
SCHEMBL1526171 0.90 FABP5 (0.40) FABP5ALDH1A1MEN1KMT2ATSHR
SCHEMBL5372417 0.88 FABP5 (0.39) FABP5ALDH1A1MEN1KMT2ATSHR
SCHEMBL5670740 0.87 FABP5 (0.39) FABP5ALDH1A1MEN1KMT2ATSHR
SCHEMBL2637405 0.87 FABP5 (0.39) FABP5MAPTMEN1KMT2ATDP1
SCHEMBL3433024 0.86 HSD17B10 (0.39) FABP5ALDH1A1TP53MAPTMEN1
SCHEMBL3805522 0.85 BMP1 (0.37) FABP5ALDH1A1MAPTMEN1KMT2A
SCHEMBL17500350 0.84 NPC1 (0.43) FABP5ALDH1A1TP53MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946562-B2 Synthesis of peptoid substituted azole compounds EASTMAN KODAK COMPANY (US) 2005-09-20 — — US disclosed
US-20030187188-A1 Synthesis of peptoid substituted azole compounds EASTMAN KODAK COMPANY 2003-10-02 — — US disclosed
EP-1319979-A1 Imaging materials containing peptoid substituted azole couplers EASTMAN KODAK COMPANY (US) 2003-06-18 — — EP disclosed
EP-1319975-A1 Synthesis of peptoid substituted azole compounds EASTMAN KODAK COMPANY (US) 2003-06-18 — — EP disclosed
US-6514679-B1 Imaging materials containing peptoid substituted azole couplers EASTMAN KODAK COMPANY 2003-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187188-A1 Synthesis of peptoid substituted azole compounds ERG28, MLNR, DNPEP FABP5 650/4885NR3C1 612/4885PTGS1 2858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback